Thursday, March 27, 2025
spot_img

EXL to Host Investor Strategy Update Event on May 6 in New York

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today announced it will be holding an investor strategy update event on May 6, at the NASDAQ MarketSite in Times Square New York.

The event will be hosted by Rohit Kapoor, chairman and chief executive officer, along with members of the EXL executive leadership team, focusing on the progression of EXL’s data and AI strategy, new operating model and latest solutions.

To register for the event, please click here. A webcast replay will be available after the event has concluded.

About ExlService Holdings
EXL (NASDAQ: EXLS) is a global data and artificial intelligence (“AI”) company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world’s leading corporations in industries including insurance, healthcare, banking and financial services, media and retail, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have more than 59,000 employees spanning six continents. For more information, visit www.exlservice.com.

Contact:
John Kristoff
Vice President, Investor Relations
+1 212 209 4613
[email protected]

Powered by SlickText.com

Hot this week

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Topics

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Chemomab Therapeutics’ Touts Positive Data From Experimental Drug For Chronic Liver Disease

Chemomab Therapeutics Ltd. CMMB on Thursday released results from the...

Vertical Aerospace Unfairly Undervalued, Says Bullish Analyst

D. Boral Capital analyst Jesse Sobelson initiated coverage on...

Petrus Resources Announces Monthly Activity Update

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img